telmisartan has been researched along with Metabolic Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z; Lu, F; Peng, J; Tang, M; Wang, Z; Zhang, H; Zhang, W; Zhao, Y; Zhong, M | 1 |
| Brunner, HR; Foster, C; Huo, Y; Michel, MC | 1 |
| Demin, AA; Shuliat'eva, OIu | 1 |
| Kajioka, T; Kitahara, Y; Miura, K; Yamagishi, S | 1 |
1 review(s) available for telmisartan and Metabolic Diseases
| Article | Year |
|---|---|
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atherosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Culture Techniques; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Gene Knockout Techniques; Glucose; Humans; Hypertension; Kidney; Lipid Metabolism; Metabolic Diseases; Oxadiazoles; Renin-Angiotensin System; Stroke; Telmisartan | 2016 |
1 trial(s) available for telmisartan and Metabolic Diseases
| Article | Year |
|---|---|
Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; China; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Metabolic Diseases; Middle Aged; Obesity; Telmisartan; Treatment Outcome | 2015 |
2 other study(ies) available for telmisartan and Metabolic Diseases
| Article | Year |
|---|---|
[New effects of telmisartan, an angiotensin 2 receptor blocker, in the treatment of arterial hypertension with metabolic disorders].
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Enalapril; Female; Humans; Hypertension; Male; Metabolic Diseases; Middle Aged; Telmisartan | 2012 |
Potential utility of combination therapy with nateglinide and telmisartan for metabolic derangements in Zucker Fatty rats.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Body Weight; Cyclohexanes; Drug Therapy, Combination; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Lipids; Male; Metabolic Diseases; Nateglinide; Phenylalanine; Rats; Rats, Zucker; Telmisartan | 2007 |